Management of Hypertension in the Asia-Pacific Region: A Structured Review

被引:0
作者
Abdul R. A. Rahman
Jose Donato A. Magno
Jun Cai
Myint Han
Hae-Young Lee
Tiny Nair
Om Narayan
Jiampo Panyapat
Huynh Van Minh
Rohit Khurana
机构
[1] An Nur Specialist Hospital,Division of Cardiovascular Medicine, Philippine General Hospital, Cardiovascular Institute
[2] University of the Philippines College of Medicine,Hypertension Center
[3] Angeles University Foundation Medical Center,Department of Internal Medicine
[4] Fuwai Hospital,Department of Internal Medicine
[5] Grand Hantha International Hospital,The Harley Street Heart and Vascular Center
[6] Seoul National University Hospital,undefined
[7] PRS Hospital,undefined
[8] The Northern Hospital,undefined
[9] Bhumibol Adulyadej Hospital,undefined
[10] Hue University of Medicine and Pharmacy,undefined
[11] Gleneagles Hospital,undefined
来源
American Journal of Cardiovascular Drugs | 2024年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This article reviews available evidence regarding hypertension management in the Asia-Pacific region, focussing on five research questions that deal with specific aspects: blood pressure (BP) control, guideline recommendations, role of renin–angiotensin–aldosterone system (RAAS) inhibitors in clinical practice, pharmacological management and real-world adherence to guideline recommendations. A PubMed search identified 2537 articles, of which 94 were considered relevant. Compared with Europeans, Asians have higher systolic/diastolic/mean arterial BP, with a stronger association between BP and stroke. Calcium channel blockers are the most-commonly prescribed monotherapy in Asia, with significant variability between countries in the rates of angiotensin-converting enzyme inhibitors (ACEis)/angiotensin-receptor blockers (ARBs) and single-pill combination (SPC) use. In clinical practice, ARBs are used more commonly than ACEis, despite the absence of recommendation from guidelines and clinical evidence supporting the use of one class of drug over the other. Ideally, antihypertensive treatment should be tailored to the individual patient, but currently there are limited data on the characteristics of hypertension in Asia-Pacific individuals. Large outcome studies assessing RAAS inhibitor efficacy and safety in multi-national Asian populations are lacking. Among treated patients, BP control rates were ~ 35 to 40%; BP control in Asia-Pacific is suboptimal, and disproportionately so compared with Western nations. Strategies to improve the management of hypertension include wider access/availability of affordable treatments, particularly SPCs (which improve adherence), effective public health screening programs targeting patients to drive health-seeking behaviours, an increase in physician/patient awareness and early implementation of lifestyle changes. A unified Asia-Pacific guideline on hypertension management with pragmatic recommendations, particularly in resource-limited settings, is essential.
引用
收藏
页码:141 / 170
页数:29
相关论文
共 623 条
  • [1] Jin CN(2013)The healthcare burden of hypertension in Asia Heart Asia. 5 238-243
  • [2] Yu CM(2020)Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet 396 1223-1249
  • [3] Sun JP(2016)Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry Eur Heart J 37 3141-3153
  • [4] Lam CS(2016)25 by 25: achieving global reduction in cardiovascular mortality Curr Cardiol Rep 18 10-716
  • [5] Teng TK(2003)Blood pressure and cardiovascular disease in the Asia Pacific region J Hypertens 21 707-648
  • [6] Tay WT(2010)A cross-national comparative study of blood pressure and hypertension between English and Dutch South-Asian- and African-origin populations: the role of national context Am J Hypertens 23 639-436
  • [7] Dugani S(2022)Correlates of undiagnosed hypertension among Chinese and Korean American immigrants J Community Health 47 425-382
  • [8] Gaziano TA(2018)Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics Hypertension 71 375-56
  • [9] Lawes CM(2011)Type 2 diabetes and cardiovascular disease in South Asians Prim Care Diabetes 5 45-1162
  • [10] Rodgers A(2020)Blood pressure and heart rate related to sex in untreated subjects: the India ABPM study J Clin Hypertens (Greenwich). 22 1154-1794